Amyris Biotechnology Inc. buy MrRIpley
Start price
23.12.21
/
0%
€5.00
Target price
23.12.22
-
Performance (%)
-22.05%
End price
13.09.22
€3.89
Summary
This prediction ended on 13.09.22 with a price of €3.89. The price of Amyris Biotechnology Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.05%.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amyris Biotechnology Inc. | - | - | - |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% |
According to MrRIpley what are the pros and cons of Amyris Biotechnology Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Undervalued
positive Cash Flow expected
Top Rating
High Investments for future growth
ROE higher than 15% per year
Capable Management
Very good company culture
Leading role in innovation
Strong uniques
Very differentiated customer and product portfolio
Growths much faster than the competition
Sustainability is very important
Management is a major shareholder
Market Leader or Top 3
Small cyclical dependencies
Known brand
Very Future proof/growth oriented business model
Cons
Very low/no dividend yield expected
Risky balance sheet
Higher risks for its business
Comments by MrRIpley for this prediction
In the thread Amyris Biotechnology Inc. diskutieren
Buy mit Kursziel 15,0